NSEGeneral Updates3d ago · 18 Sept 2026, 06:18 pm

General Updates

Religare Enterprises Limited · RELIGARE

✦ AI SummaryFundraise

Religare Enterprises Limited has informed the Exchange about General Updates, specifically that its material subsidiary, Care Health Insurance Limited, has allotted 10,000 debentures worth Rs. 100 Crore at a coupon rate of 10% p.a. These debentures will be listed on the Debt Segment of National Stock Exchange of India Limited from September 22, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Religare Enterprises Limited has informed the Exchange about General Updates

Attachments (1)

📄

RELIGARE_18092026181658_RELUPDATE06082026_CHIL.pdf

pdf

Download →
View document text
September 18, 2026 The National Stock Exchange of India Ltd. BSE Limited Corporate Communications Department Corporate Services Department “Exchange Plaza”, 5th Floor, Phiroze Jeejeebhoy Towers Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400051 Mumbai – 400001 Scrip Symbol: RELIGARE Scrip Code: 532915 Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir(s), With reference to the captioned subject, we would like to inform you that Care Health Insurance Limited (“CHIL”), a material subsidiary of Religare Enterprises Limited (“the Company”), has allotted 10,000 (Ten Thousand) Debentures (unsecured, subordinated, listed, taxable, rated, redeemable, non-cumulative, non- convertible debentures in the nature of ‘Subordinated Debt’ at a coupon rate fixed at 10.00% p.a.) each bearing a face value of Rs. 1,00,000 (Rupees One Lakh) aggregating to Rs. 100 Crore (Rupees One Hundred Crore), for cash, at par, in dematerialized form. Please see Annexure A for the details of the Debentures issued by the CHIL. Further, the aforesaid Debentures will be listed on Debt Segment of National Stock Exchange of India Limited w.e.f. September 22, 2026. This is for your kind information and record. Thanking You For Religare Enterprises Limited Babu Rao P. Group General Counsel & Group Chief Compliance Officer Religare Enterprises Limited CIN: L74899DL1984PLC146935 Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692 Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941 www.religare.com / investorservices@religare.com Annexure A Sr. No. Particulars Remarks 1. Issuer Care Health Insurance Limited 2. Type of securities Listed, unsecured, subordinated, rated, redeemable, taxable, non- proposed to be issued cumulative, non-convertible debentures in the nature of ‘Subordinated Debt’ in accordance with the “IRDAI Laws and SEBI NCS Regulations. The Debentures shall be fully paid up in cash. 3. Type of issuance Non-convertible debentures in the nature of subordinated debt instruments, on a private placement basis 4. Size of issue Rs. 100,00,00,000 (Rupees One Hundred Crore). 5. Whether proposed to be Yes. National Stock Exchange of India Limited listed? If yes, name of the stock exchange(s) 6. Tenure of the instrument Tenor: 10 (Ten) years from the deemed date of allotment, subject to the – date of allotment and exercise of any call option by the Company at the end of 5 (Five) years date of maturity and every year thereafter. Date of allotment: 18 September, 2026 Date of maturity: 18 September, 2036, subject to exercise of any Call Option by the Company. 7. Coupon / interest offered, Coupon Rate: 10% per annum schedule of payment coupon/interest and Schedule of payment of interest and principal: principal The Debentures shall be redeemed at par 10 (Ten) years from the deemed date of allotment, on 18 September, 2036, subject to the exercise of any call option by the Company at the end of 5 (Five) years and every year thereafter. The Debentures shall carry interest in accordance with the term sheet as set out in the key information document dated 17 September, 2026, on the outstanding principal amount of Debentures until the redemption date. The following terms and conditions shall be applicable in relation to any Interest payment to be made by the Issuer pursuant to this Issue: (i) the Interest or Default Interest (if applicable) on the Debentures shall be charged to the profit and loss account of the Issuer, and will be paid annually; (ii) the Issuer shall not be liable to pay the Interest or any Default Interest (if applicable) for that financial year, if the payment of such Interest is prohibited in terms of IRDAI Laws; (iii) prior approval of IRDAI shall be required for payment of Interest or any Default Interest (as applicable) for any financial year, if: (a) the impact of accrual or payment of Interest or any Default Interest (as applicable) may result in net loss or increase in the net loss of the Issuer; (b) solvency margin of the Issuer is below the Control Level of Solvency; or (c) the impact of such accruing or paying such Interest or Default Interest (if applicable) would result in the Control Level of Solvency of the Issuer falling below or remaining below the regulatory requirements prescribed by the IRDAI; (iv) any Interest or Default Interest shall not be cumulative i.e., the Interest missed in a year will not be paid in the future years. The Issuer is permitted (but not obliged) to cumulate Interest Religare Enterprises Limited CIN: L74899DL1984PLC146935 Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692 Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941 www.religare.com / investorservices@religare.com which is not paid on an Interest Payment Date, and pay such Interest on a subsequent Interest Payment Date compounded on an Actual/Actual basis and in compliance with all Applicable Laws (including but not limited to IRDAI Laws). It is hereby explicitly clarified that any cancellation of servicing of the Debentures or non-payment of Interest or Default Interest (if applicable), or the payment of any Interest in the subsequent financial years by the Issuer, in the manner set out hereinabove shall not be construed to be an Event of Default or be construed to be a breach of the Transaction Documents of any manner and no restriction or obligation on the Issuer of any kind whatsoever, including any obligation to pay Default Interest, shall be imposed or be deemed to have been imposed on the Issuer upon the occurrence of such an event except that the Issuer shall not distribute any dividend to its equity shareholders. Payment of Interest or Default Interest (if applicable) shall be subject to IRDAI Laws at all times. The calling of an Event of Default on account of, any event of non-payment of Interest or Default Interest (if applicable), of the Debentures by the Issuer shall be subject to the IRDAI Laws on the date of calling of the said Event of Default. 8. Charge / security, if any, Not applicable created over the assets 9. Special right/ interest/ Not applicable privileges attached to the instrument and changes thereof 10. Delay in payment of Not applicable interest/ principal amount for a period of more than three months from the due date or default in payment of interest/ principal 11. Details of any letter or Not applicable comments regarding payment / non-payment of interest, principal on due dates, or any other matter concerning the security and/ or the assets along with its comments thereon, if any 12. Details of redemption of Not applicable preference shares indicating the manner of redemption (whether out of profits or out of fresh issue) and debentures 13. Any cancellation or Not applicable termination of proposal for issuance of securities including reasons thereof. Religare Enterprises Limited CIN: L74899DL1984PLC146935 Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055 Phone No.: +91-11- 4167 9692 Corporate Office: 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh Phone No.: +91-120- 4384 941 www.religare.com / investorservices@religare.com